Bhandari S et al. |
A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients. |
2015 |
Nephrol. Dial. Transplant. |
pmid:25925701
|
Toblli JE et al. |
Cardiovascular outcomes of intravenous iron in perspective of clinical trials and the use of different iron preparations. |
2015 |
Int. J. Cardiol. |
pmid:25838213
|
Dai P et al. |
Triple Recycling Processes Impact Systemic and Local Bioavailability of Orally Administered Flavonoids. |
2015 |
AAPS J |
pmid:25762448
|
Toblli JE et al. |
Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron. |
2015 |
Heart Lung Circ |
pmid:25666998
|
Shiue E et al. |
Improving product yields on D-glucose in Escherichia coli via knockout of pgi and zwf and feeding of supplemental carbon sources. |
2015 |
Biotechnol. Bioeng. |
pmid:25258165
|
Pieracci FM et al. |
A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness*. |
2014 |
Crit. Care Med. |
pmid:24797376
|
Hetzel D et al. |
A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy. |
2014 |
Am. J. Hematol. |
pmid:24639149
|
Perelló MF et al. |
Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial. |
2014 |
BJOG |
pmid:24423186
|
Toyokuni S |
Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis. |
2014 |
Redox Rep. |
pmid:24257681
|
Onken JE et al. |
Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. |
2014 |
Nephrol. Dial. Transplant. |
pmid:23963731
|